ACS患者血清五聚素3水平变化及其与冠脉病变范围、近期预后的相关性研究

方晗; 谢楠; 夏珂; 秦莉峰; 杨天伦

doi:10.13201/j.issn.1001-1439.2014.07.010

ACS患者血清五聚素3水平变化及其与冠脉病变范围、近期预后的相关性研究

- 1 中南大学湘雅医院心内科(长沙, 410008);
- 2 中南大学湘雅二医院骨科

详细信息

通讯作者: 杨天伦,E-mail:tianluny@163.com

中图分类号: R541.4

收稿日期: 2013-09-15

Serum level of Pentraxin 3 and its correlation with coronary artery lesions and short-term prognosis in patients with acute coronary syndromes

- 1 Department of Cardiology, Xiangya Hospital, Central South University, Changsha, 410008, China;
- 2 Department of Orthopedics, The Second Xiangya Hospital, Central South University

More Information

Corresponding author: YANG Tianlun, E-mail: tianluny@163.com

Received Date: 15 September 2013

摘要

摘要: 目的:了解急性期蛋白五聚素3 (PTX3) 在急性冠状动脉综合征 (ACS) 患者血清中的水平变化, 以及PTX3与冠脉病变范围、近期预后的关系。方法:收集我院心内科住院的冠心病 (CHD) 患者126例, 其中不稳定型心绞痛 (UAP组) 51例, 急性心肌梗死 (AMI组) 50例, 稳定型心绞痛 (SAP组) 25例, 选择同期在我院体检中心健康体检者 (NC组) 25例作为对照组。采用ELISA检测各组入院时空腹血清PTX3水平, 以及ACS患者 (UAP组+AMI组) 在入院规范治疗1周后的血清PTX3水平, 比较不同冠脉病变支数组的血清PTX3水平, 出院后3个月对ACS患者进行电话随访, 了解患者的近期预后。结果:①UAP组、AMI组的血清PTX3水平明显高于SAP组、NC组 (P＜0.05);SAP组PTX3水平亦高于NC组 (P＜0.05);而UAP组与AMI组的血清PTX3水平无差异。②ACS患者经过1周规范治疗后, 复查的血清PTX3水平较入院时显著降低 (P＜0.01);但仍高于NC组的正常水平 (P＜0.01)。③冠脉双支病变组和3支病变组的血清PTX3水平明显高于单支病变组 (P＜0.05);④血清PTX3、hs-CRP和TC影响ACS患者的近期预后 (死亡或因心脏事件再住院) (P＜0.05)。结论:ACS患者血清PTX3水平显著升高, 随冠脉病变支数的增加, 血清PTX3水平增高。血清PTX3水平增高提示ACS患者近期预后不良。
- 急性冠状动脉综合征 /
- 五聚素3 /
- 炎性因子
Abstract: Objective: To explore serum level change of pentraxin 3 (PTX3) in patients with acute coronary syndrome (ACS), and the relationship between PTX3 and the branch number of coronary artery stenosis and shortterm prognosis.Method: The 126 patients with coronary artery disease including unstable angina pectoris (UAP, n=51), acute myocardial infarction (AMI, n=50), stable angina pectoris (SAP, n=25) and healthy people (NC, n=25) were enrolled in this study.Serum level of PTX3 was detected by ELISA at admission and after one week treatment in the ACS patients.Serum level of PTX3 was compared in ACS patients with different branch number of coronary artery stenosis.The short-term prognosis of patients with ACS were evaluated by phone follow-up after 3months.Result: ①Serum level of PTX3 in UAP group and AMI group were significantly higher than that in SAP group and NC group (P＜0.05).The level in SAP group was also higher than that in NC group (P＜0.05).There was no significant difference between UAP group and AMI group.②After one week standard treatment, the serum level of PTX3 in patients with ACS was significantly lower than that at admission (P＜0.01), but still higher than normal level of healthy controls (P＜0.01).③Serum level of PTX3 in two and three coronary lesions group was significantly higher than that in one coronary lesions group (P＜0.05).④Short-term prognosis of patients with ACS was affected by PTX3, hs-CRP and TC (P＜0.05).Conclusion: Serum level of PTX3 is significantly elevated in patients with ACS.With the increase in number of coronary lesion, serum level of PTX3 elevated in patients with ACS.Increased serum PTX3 indicates poor short-term prognosis of patients with ACS.
- acute coronary syndromes /
- pentraxin 3 /
- inflammatory factor

HTML全文

参考文献(18)

[1]	HOLLAN I, BOTTAZZI B, CUCCOVILLO I, et al.Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease[J].Arthritis Care Res, 2010, 62:378-385.
[2]	INOUE K, SUGIYAMA A, REID P C, et al.Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris[J].Arterioscler Thromb Vasc Biol, 2007, 27:161-167.
[3]	KUNES P, LONSKV, MAND'K J, et al.Essential PTX3 biology (not only) for cardiologists and cardiac surgeons[J].Acta Medica (Hradec Kralove), 2007, 50:29-33.
[4]	PERI G, INTRONA M, CORRADI D, et al.PTX3, aprototypical long pentraxin, is an early indicator of acute myocardial infarction in humans[J].Circulation, 2000, 102:636-641.
[5]	SALIO M, CHIMENTI S, DE ANGELIS N, et al.Cardioprotective function of the long pentraxin PTX3 in acute myoca rdial infarction[J].Circulation, 2008, 117:1055-1064.
[6]	STENVINKEL P.Inflammation in end-stage renal disease:the hidden enemy[J].Nephrology, 2006, 11:36-41.
[7]	BREVIARIO F, D'ANIELLO E M, GOLAY J, et al.Interleukin-1-inducible genes in endothelial cells:cloning of a new gene related to C-reactive protein and serum amyloid P component[J].J Biol Chem, 1992, 267:22190-22197.
[8]	LEE G W, GOODMAN A R, LEE T H, et al.Relationship of TSG-14protein to the pentraxin family of major acute phase proteins[J].J Immunol, 1994, 153:3700-3707.
[9]	ROLPH M S, ZIMMER S, BOTTAZZI B, et al.Production of the long pentraxin PTX3 in advanced atherosclerotic plaques[J].Arterioscler Thromb Vasc Biol, 2002, 22:e10-e14.
[10]	张娆娩, 张菲斐, 常学伟, 等.急性冠状动脉综合征患者血浆五聚素3水平研究[J].中国综合临床, 2008, 24 (8):763-765.
[11]	贺兆发, 马显华, 金梅花, 等.冠心病患者血浆正五聚蛋白一3、血清超敏C一反应蛋白与血脂的相关性[J].心血管康复医学杂志, 2010, 19:145-147.
[12]	YUNOSUKE M.Different distribution of pentraxin 3and C-reactive protein in coronary atherosclerotic plaques[J].J Atheroscler Thromb, 2012, 19:837-845.
[13]	KOTOOKA N, INOUE T, FUJIMATSU D, et al.Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening[J].Atherosclerosis, 2008, 197:368-374.
[14]	TONG M, ANDERSTAM B, SJÖBERG B, et al.Circulating levels of long Pentraxin 3 (PTX3) are elevated in hemodialysis patients and increase acutely after a single HD session[J].J Am Soc Nephrol, 2006, 17:735-740.
[15]	LATINI R, MAGGIONI A P, PERI G, et al.Prognostic signi?cance of the long pentraxin PTX3 in acute myocardial infarction[J].Circulation, 2004, 110:2349-2354.
[16]	SHIGERU M, JUNNICHI I, FUMIHIKO K, et al.Pentraxin 3in unstable angina and non-ST-segment elevation myocardial infarction[J].Atherosclerosis, 2010, 210:220-225.
[17]	NORIHIKO K, TERUO I, SHIGEHISA A, et al.Prognostic value of pentraxin 3in patients with chronic heart failure[J].Int J Cardiol, 2008, 130:19-22.
[18]	JENNY N S, ARNOLD A M, KULLER L H, et al.Associations of pentraxin 3with cardiovascular disease and all-cause death:the Cardiovascular Health Study[J].Arterioscler Thromb Vasc Biol, 2009, 29:594-599.